共 157 条
[1]
Stamey TA(1987)Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 909-916
[2]
Yang N(2010)Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes Urology. 76 1072-1076
[3]
Hay AR(2014)Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer J Clin Oncol 32 671-677
[4]
McNeal JE(2015)Integrative clinical genomics of advanced prostate cancer Cell 161 1215-1228
[5]
Freiha FS(2014)Tumor clone dynamics in lethal prostate cancer Sci Transl Med 6 254ra125-8261
[6]
Redwine E(2005)Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis J Clin Oncol 23 8253-790
[7]
Carvalhal GF(2009)Development of a second-generation antiandrogen for treatment of advanced prostate cancer Science 324 787-1197
[8]
Daudi SN(2012)Increased survival with enzalutamide in prostate cancer after chemotherapy N Engl J Med 367 1187-433
[9]
Kan D(2014)Enzalutamide in metastatic prostate cancer before chemotherapy N Engl J Med 371 424-230
[10]
Mondo D(2015)Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial Eur Urol 67 223-1159